Skip to content
CoverageCARC

CO-55 denial code

Procedure or drug is deemed experimental or investigational

The payer classifies the service as unproven under its policy.

How to fix it

Appeal with peer-reviewed literature and the payer's own policy criteria. Obtain an advance notice where the patient may be billed.

How to prevent it

Check the payer's medical policy before scheduling anything novel; this denial is predictable from published policy.

In practice

A practice performs a newer minimally invasive procedure for chronic back pain. The claim returns CO-55: the payer classifies the procedure as investigational under its medical policy.

The appeal that works is not a letter describing how well the patient did. It is a response written against the payer's own published policy, addressing each criterion the policy sets for coverage and attaching the peer-reviewed literature the policy asks for.

The appeal that fails is the one that argues the payer's policy is out of date. It may be — payer policies frequently lag the evidence by years — but the reviewer reading the appeal applies the policy as written and has no authority to do otherwise.

What sits behind it

CO-55 is almost entirely predictable. Every major payer publishes its medical policies, and a procedure classified as investigational is classified that way in a document anyone can read before the patient is scheduled. A CO-55 denial usually means nobody looked.

The financial exposure is what makes it worth the check. Investigational procedures tend to be expensive, and because the classification is a coverage position rather than a medical necessity judgement, the appeal success rate is low. A practice that performs the service first and discovers the policy afterwards has usually lost the revenue.

The patient conversation is the part that gets neglected. Where a service is likely to be classified as investigational, the patient can accept financial responsibility in advance — but only if they are told before the procedure, in writing, with the expected cost. Presenting that after a denial reads as billing a patient for a decision they were never part of.

Related codes

Terms used here — Medical Necessity · Prior Authorization · Appeal

How we handle it — Prior Authorization · Denial Management · Medical Coding

Primary sources

The rules behind CO-55, at the bodies that publish them.

Every denial code with a guide

Liability and workers comp

Looking for a different code? Search all 190 CARC and RARC codes

Questions about CO-55

Sometimes, but the appeal has to work inside the payer's own medical policy rather than around it. That means addressing each coverage criterion the policy states and attaching the peer-reviewed evidence it asks for. Arguing that the policy is outdated does not succeed, because the reviewer applies the policy as written.

FDA approval and payer coverage are separate decisions with different standards. A payer classifies a service as investigational when it judges the published evidence insufficient for its coverage criteria, which is a policy position rather than a clinical or regulatory one.

Yes, if they accepted financial responsibility in writing before the service, with the expected cost stated. Without that, most payer contracts prevent transferring the balance, and presenting the bill after the fact is a poor position to be in either way.

Read the payer's medical policy for the specific procedure before scheduling. This denial is published in advance more reliably than almost any other, which makes it one of the few that is genuinely preventable by reading rather than by process change.

Find out what your denials are costing you

A free billing audit reviews your denial rate, AR aging and clean claim rate against industry benchmarks. Takes about two minutes to request. No sales pitch.

No setup fees · You pay when we collect · Pricing from 3% of net collections